Provision of Near-Patient Testing Service. Service Level Agreement Background. 2. Financial Details
|
|
- Job Sutton
- 5 years ago
- Views:
Transcription
1 Provision of Near-Patient Testing Service Service Level Agreement Contents: 1. Financial Details 2. Service Aims 3. Criteria 4. Ongoing Measurement & Evaluation 5. Accreditation 1. Background Originally commissioned in 2004, the Near Patient Testing was aimed at monitoring those patients currently being prescribed a range of drugs particularly focussed in the field of Rheumatology following an agreed shared care plan with secondary care as evidence shows the incidence of side effects can be reduced if shared care plan monitoring is carried out in a well organised way, close to the patients home 1. In the guidelines 2, the British Society for Rheumatology (2008) discussed various DMARD s, all of which are included in this service (excluding Hydroxychloroquine) due to minimal use and minimal monitoring respectively. 2. Financial Details This agreement is to cover the 36 months commencing 1 April Each practice contracted to provide this service will receive a monthly payment in line with prior year activity. Payment adjustments will be made quarterly based on actual activity levels calculated as 25% of the annual contract value detailed below times the number of patients in each quarter. For example 5 patients on Leflunomide (only) in Q1 will generate a payment of 5 (patients) x 10 (i.e. a quarter of the 40pa payment). Where a patient is receiving shared care across multiple drugs; only one monitoring payment at the highest level relevant to those drugs will be made. For example, if a patient is on Azathioprine (level 3) and Denosumab (level 1) payment will be at level three. 1 British Society for Rheumatology (2008) BSR/BHPR Guideline for Disease-modifying Anti-rheumatic Drug (DMARD) Therapy in Consultation with the British Association of Dermatologists, Oxford University Press 2 British Society for Rheumatology (2008) BSR/BHPR Guideline for Disease-modifying Anti-rheumatic Drug (DMARD) Therapy in Consultation with the British Association of Dermatologists, Oxford University Press
2 Shared Care Drugs Monitoring Intensity Levels Payment per patient Per Annum Azathioprine Ciclosporin Mercaptopurine Dronedarone Methotrexate Year 1 Denosumab Sodium Aurothiomalate Dronedarone Sulfasalazine Leflunomide Mycophenolate Penicillamine Sulfasalazine Level One Level One Level One - Year 2 onwards Level One - Year 2 Level Two Level Two Level Two Level Two Year 1 Practices will be requested to complete quarterly activity returns in 2016/17 which the CCG will reconcile against activity reports run centrally from TPP SystmOne and equivalent clinical systems. Through discussion with practices differences will be identified and agreed in order to eliminate future differences throughout 2016/17. Quarterly payment adjustments will be made based on agreed actual activity levels. From 2017/18 onwards it is envisaged that the CCG will run central searches in order to make quarterly payment adjustments based on actual activity, following the alignment of activity reporting within 2016/17. In signing up to this service the practice agrees to recording patient activity using the read codes above, and agrees for the CCG to reconcile quarterly activity returns to central reports run based on these read codes, for payment and audit purposes. Practices will be paid where they have accepted responsibility for monitoring patients according to locally agreed shared care guidance or a care plan agreed with secondary care for that patient. The CCG reserves the right to make changes to, add, amend or cancel this service with three months given notice. 3. Service Aims The treatment of several diseases within the fields of medicine is increasingly reliant on drugs that, while clinically effective, need regular blood monitoring. This is due to the potentially serious side-effects that these drugs can occasionally cause. It has been shown that the incidence of side-effects can be reduced significantly if this monitoring is carried out in a well-organised way, close to the patient s home. The near patient testing service is designed to be one in which: (i) Therapy should only be started for recognised indications for specified lengths of time (ii) Maintenance of patients first stabilised in the secondary care setting should be properly controlled (iii) The service to the patient is convenient (iv) The need for continuation of therapy is reviewed regularly
3 (v) The therapy is discontinued when appropriate (vi) The use of resources by the National Health Service is efficient. 4. Criteria All practices are expected to provide essential services as well as additional services they are individually contracted to provide to all their patients. This enhanced service specification outlines the more specialised services to be provided. The specification of this service is designed to cover the enhanced aspects of clinical care of the patient all of which are beyond the scope of essential services. No part of the specification by commission, omission or implication defines or redefines essential or additional services. Different amber drugs require different levels of monitoring. There are three levels of monitoring intensity levels being proposed within the proposed contract: high intensity blood monitoring required. A shared care drug monitoring service including frequent blood testing, in respect of the following drugs: Drug Azathioprine Ciclosporin Mercaptopurine Methotrexate Dronedarone (Year One only) Indication Arrhythmias Level Two medium/low intensity blood monitoring. Monitoring including blood testing, in respect of the following drugs: Drug Leflunomide Mycophenolate Penicillamine Sulfasalazine (Year One only) Indication Level One routine monitoring only, in respect of the following: Drug Sulfasalazine (Year Two only) Denosumab Sodium Aurothiomalate Dronedarone (Year Two onwards) Indication Osteoporosis Arrhythmias This service will fund: (i) A shared care drug monitoring service in respect of the following specified drugs: Azathioprine Ciclosporin Leflunomide Mercaptopurine Mycophenolate Denosumab Dronedarone Penicillamine
4 Sulfasalazine Methotrexate Sodium Aurothiomalate In accordance with local shared care agreements (SCAs) or individually agreed care plans. For the drugs included in the service, the following monitoring requirements are specified in the SCAs. GP Responsibilities: 1 Reply to the request for shared care as soon as practicable. 2 Prescribe the drug at the dose recommended. 3 Carry out monitoring according to the guideline recommendations. 4 Ensure the patient is aware of any treatment change and that where held, the monitoring booklet is up to date. 5 Report to and seek advice from the specialist on any aspect of patient care that is of concern and may affect treatment. 6 Refer patient to specialist if his or her condition deteriorates. 7 Stop treatment on the advice of the specialist or immediately if an urgent need to stop treatment arises. 8 Report adverse events to the specialist team and to the MHRA via the yellow card scheme. Monitoring should be as per local shared care agreements found at the following links: BCAP Formulary (RUH): Care_DMARD_monitoring_guidelines-30th-Sept-2015.pdf 3Ts formulary (GWH): See Rheumatology section at bottom of page. ICID formulary (SFT): There are currently no shared care agreements available, so please use those available from 3Ts or BCAP formulary. The general responsibilities for ALL of the drugs are as follows: (ii) A register. Practices should be able to produce and maintain an up-to-date register of all shared care drug monitoring service patients, indicating: patient name date of birth indication and duration of treatment date practice accepted responsibility for monitoring last hospital appointment. (iii) Call and recall. To ensure that systematic call and recall of patients on this register is taking place. (iv) Continuing information for patients. To ensure that all patients, (and/or their carers and support staff when appropriate), are informed of how to access appropriate and relevant information. (v) Professional links. To work together with other professionals when appropriate. Any health care professionals involved in the care of patients in the programme should be appropriately trained.
5 (vi) Referral policies. Where appropriate to refer patients promptly to other necessary services and to the relevant support agencies using locally agreed guidelines where these exist. (vii) Record keeping. To maintain adequate records of the service provided, incorporating all known information relating to any significant events e.g. hospital admissions, death of which the practice has been notified. (viii) Training. Each practice must ensure that all staff involved in providing any aspect of care under this scheme has the necessary training and skills to do so. Staff are expected to keep up-to-date with current evidence and guidance. 5. Ongoing Measurement & Evaluation Untoward events It is a condition of participation in this service that practitioners will give notification, in addition to their statutory obligations, within 72 hours of the information becoming known to him/her, to the CCG clinical governance lead of all emergency admissions or deaths of any patient covered under this service, where such admission or death is or may be due to usage of the drug(s) in question or attributable to the relevant underlying medical condition. Annual review All practices involved in the scheme should perform an annual review, which could include: (a) Brief details as to arrangements for each of the aspects highlighted in the service (b) Details of any computer-assisted decision-making equipment used and arrangements for internal and external quality assurance (c) Details of any near-patient testing equipment used and arrangements for internal and external quality assurance (d) Details of training and education relevant to the drug monitoring service (e) Details of the standards used for the control of the relevant condition (f) Assurance that any staff member responsible for prescribing has the necessary skills to prescribe safely. Clinical System Searches Year 1 practice will continue to submit manual returns for this service. These will be reconciled on a quarterly basis with information from the central reporting unit for TPP SystmOne and equivalent searches for other clinical systems. The central reporting searches will be shared across all practices to allow identification of any anomalies and unified agreed search criteria for year 2. Year 2 and 3 Data will be collated using the central reporting unit for TPP SystmOne and equivalent searches for other clinical systems. No reporting required from individual practices. Note, the central reporting searches to allow identification of medication prescribed by a secondary care provider (e.g. hospital prescribed medication). Instructions on how to record these drugs are available here: 6. Accreditation
6 Those doctors who have previously provided services similar to the proposed service and who satisfy at appraisal and revalidation that they have such continuing medical experience, training and competence as is necessary to enable them to contract for the enhanced service shall be deemed professionally qualified to do so.
PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE
PROPOSAL TO UPDATE NEAR PATIENT TESTING ENHANCED SERVICE 1.0 ACTION BY AWMSG: The All Wales Medicines Strategy Group (AWMSG) meeting held on 15 th December 2010 considered and approved the recommendations
More informationAnti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted
More informationANTI-COAGULATION MONITORING
ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This
More informationInitiation of Warfarin for patients not registered with Provider Practice
Initiation of Warfarin for patients not registered with Provider Practice 2017-18 1. Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called Initiation of Warfarin
More informationClinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session Date of Meeting: 22 March 2016 For: Decision Discussion Noting
Clinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session Date of Meeting: 22 March 2016 For: Decision Discussion Noting PRIVATE session Agenda Item and title: Author: Lead Director/GP
More informationLinda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies
Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and
More informationQuality Standards for Enhanced Primary Care Services. Version 1.2
Quality Standards for Enhanced Primary Care Services Version 1.2 September 2014 8831 September 2014 West Midlands Quality Review Service These Quality Standards may be reproduced and used freely by NHS
More informationOxfordshire Primary Care Commissioning Committee. Date of Meeting: 3 January 2017 Paper No: 9
Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 3 January 2017 Paper No: 9 Title of Presentation: OCCG Primary Care Locally Commissioned Services
More informationThis SLA covers an enhanced service for care homes for older people and not any other care category of home.
Care Homes for Older People Service Level Agreement 2016-2019 All practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This service
More informationEnhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people
Enhanced service specification Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 1 Enhanced service specification Avoiding unplanned admissions: proactive case
More informationCrawley CCG LCS Dec 15 Final
Crawley CCG LCS Dec 15 Final Crawley CCG Service Proposal for the inclusion of administration and monitoring of Denosumab 60mg Injection (Prolia )in GP Practices under a Locally Commissioned Service February
More informationEnhanced service specification. Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 2016/17
Enhanced service specification Avoiding unplanned admissions: proactive case finding and patient review for vulnerable people 2016/17 NHS England INFORMATION READER BOX Directorate Medical Commissioning
More informationCommissioning Policy
Commissioning Policy Consultant to Consultant Referrals Version 6.0 December 2017 Name of Responsible Board / Committee for Ratification: North Staffordshire CCG Stoke on Trent CCG Date Issued: November
More informationSafer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the
More information3. The requirements for taking part in the ES are as follows:
Enhanced Service Specification Learning disabilities health check scheme Background and purpose 1. This enhanced service (ES) is designed to encourage practices to identify all patients aged 14 and over
More informationGMS Contract in Wales Enhanced Service for Care Homes Specification
GMS Contract in Wales 2008-09 Enhanced Service for Care Homes Specification Doc 5 1. Introduction Many older people enter care homes to receive supportive care and these populations have increasing dependency
More informationNational Enhanced Service (NES) for Intra-uterine contraceptive device fittings and contraceptive implants
National Enhanced Service (NES) for Intra-uterine contraceptive device fittings and contraceptive implants Service Level Agreement PRACTICE Contents: 1. Finance Details 2. Signature Sheet 3. Service Aims
More informationSchedule C1. Community Pharmacy Anti-Coagulation Management Services
Schedule C1 Community Pharmacy Anti-Coagulation Management Services 1. Definition This service specification relates to the anticoagulation management of Service Users on warfarin by an accredited community
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationUpdate on co-commissioning of primary care: guidance for CCG member practices and LMCs
Update on co-commissioning of primary care: guidance for CCG member practices and LMCs British Medical Association bma.org.uk This paper is an update of previous GPC (general practitioners committee) guidance
More informationNHS 111 Clinical Governance Information Pack
NHS 111 Clinical Governance Information Pack This pack is designed to help you develop your local NHS 111 clinical governance framework and explain how it fits in to the wider context. It takes you through
More informationReady for revalidation. Supporting information for appraisal and revalidation
2012 Ready for revalidation Supporting information for appraisal and revalidation During their annual appraisals, doctors will use supporting information to demonstrate that they are continuing to meet
More informationCamden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly
Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly
More informationMental Health (Wales) Measure Implementing the Mental Health (Wales) Measure Guidance for Local Health Boards and Local Authorities
Mental Health (Wales) Measure 2010 Implementing the Mental Health (Wales) Measure 2010 Guidance for Local Health Boards and Local Authorities Januar y 2011 Crown copyright 2011 WAG 10-11316 F6651011 Implementing
More informationHow NICE clinical guidelines are developed
Issue date: January 2009 How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS Fourth edition : an overview for stakeholders, the public and the NHS Fourth edition
More informationSERVICE SPECIFICATION FOR THE PROVISION OF LONG-ACTING REVERSIBLE CONTRACEPTION SUB-DERMAL CONTRACEPTIVE IMPLANTS IN BOURNEMOUTH, DORSET AND POOLE
Revised for: 1 April 2015 Updated: 16 April 2015 Appendix 2.2 SERVICE SPECIFICATION FOR THE PROVISION OF LONG-ACTING REVERSIBLE CONTRACEPTION SUB-DERMAL CONTRACEPTIVE IMPLANTS IN BOURNEMOUTH, DORSET AND
More informationPre-registration. e-portfolio
Pre-registration e-portfolio 2013 2014 Contents E-portfolio Introduction 3 Performance Standards 5 Page Appendix SWOT analysis 1 Start of training plan 2 13 week plan 3 26 week plan 4 39 week plan 5 Appraisal
More informationImproving compliance with oral methotrexate guidelines. Action for the NHS
Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication
More informationPutting Barnsley People First. Quality and Patient Safety Committee Terms of Reference
Putting Barnsley People First Quality and Patient Safety Committee Terms of Reference 1. Introduction NHS Barnsley Clinical Commissioning Group Quality and Patient Safety Committee 1.1 The Clinical Commissioning
More informationPATIENT SAFETY AND QUALITY COMMITTEE TERMS OF REFERENCE
PATIENT SAFETY AND QUALITY COMMITTEE TERMS OF REFERENCE Page 1 DOCUMENT CONTROL SHEET Name of Document: Patient Safety and Quality Committee Terms of Reference Version: 5 File Location / Document Name:
More informationPrescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services
Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing
More informationREQUIREMENT. Identify a minimum of 4 theme areas which are considered to have caused concern for patients during 2012/13
2012/13 SSOTP CQUIN INDICATOR TARGETS INDICATOR REQUIREMENT 1. Patient Experience Milestone 1 (15th working day of April 2012) Identify a minimum of 4 theme areas which are considered to have caused concern
More informationThe Mental Health (Wales) Measure Part 1 Scheme. Local Primary Mental Health Support Services. for
The Mental Health (Wales) Measure 2010 Part 1 Scheme Local Primary Mental Health Support Services for BETSI CADWALADR UNIVERSITY HEALTH BOARD ANGLESEY COUNTY COUNCIL GWYNEDD COUNCIL CONWY COUNTY BOROUGH
More informationImplementation of the right to access services within maximum waiting times
Implementation of the right to access services within maximum waiting times Guidance for strategic health authorities, primary care trusts and providers DH INFORMATION READER BOX Policy HR / Workforce
More informationBOARD PAPER - NHS ENGLAND. Internal Delegation arrangements for Greater Manchester Devolution
Paper: PB.31.03.16/08 BOARD PAPER - NHS ENGLAND Title: Internal Delegation arrangements for Greater Manchester Devolution Lead Director: Paul Baumann, Chief Financial Officer Karen Wheeler, National Director:
More informationA. Commissioning for Quality and Innovation (CQUIN)
A. Commissioning for Quality and Innovation (CQUIN) CQUIN Table 1: Summary of goals Total fund available: 3,039,000 (estimated, based on 2015/16 baseline) Goal Number 1 2 3 4 5 Goal Name Description of
More informationNICE Charter Who we are and what we do
NICE Charter 2017 Who we are and what we do 1. The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing evidence-based guidance on health and
More informationInformation shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
More informationQuality Accounts: Corroborative Statements from Commissioning Groups. Nottingham NHS Treatment Centre - Corroborative Statement
Quality Accounts: Corroborative Statements from Commissioning Groups Quality Accounts are annual reports to the public from providers of NHS healthcare about the quality of services they deliver. The primary
More informationMINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1
FORUM FOR EXCHANGE OF INFORMATION ON ENFORCEMENT Adopted at the 9 th meeting of the Forum on 1-3 March 2011 MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1 MARCH 2011 1 First edition adopted at the 6
More informationBest Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationAuthor: Kelvin Grabham, Associate Director of Performance & Information
Trust Policy Title: Access Policy Author: Kelvin Grabham, Associate Director of Performance & Information Document Lead: Kelvin Grabham, Associate Director of Performance & Information Accepted by: RTT
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting 16 th November 2017 2. Title of Report: 3. Key Messages: BUPA ceased to be the registered provider of Crawfords Walk Nursing Home in October. The
More informationNLC in Rheumatology: service setup, practical issues, quality assurance and auditing
NLC in Rheumatology: service setup, practical issues, quality assurance and auditing Tricia Cornell Rheumatology Consultant Nurse Abbvie Honorary Senior Rheumatology Practitioner Poole Hospital NHS Foundation
More informationStandard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services
Standard Operating Procedure for the administration of Red and Amber Drugs within Integrated Community Care Services Reference No: Version: 1 Author: Emma Baggaley First Issued On: 1 st March 2018 Latest
More informationAny Qualified Provider: your questions answered
Any Qualified Provider: your questions answered September 8, 2011 These answers cover a range of questions about the detail of Any Qualified Provider on integrated care, competition and procurement, liability
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting: 2. Title of Report: Finance, Performance and Commissioning Committee Report 3. Key Messages: At the end of March 2017 the clinical commissioning
More informationConsultation Group: See relevant page in the PGD. Review Date: October 2015
Patient Group Direction For The Supply Of Trimethoprim For The Treatment Of Women With Uncomplicated Urinary Tract Infections By Nurses And Pharmacists Working Within NHS Grampian Community Pharmacies
More informationRevalidation Annual Report
Paper 31 14 Revalidation Annual Report 2013-14 Purpose of Document: To provide the Board with a report on the first year s experience with medical revalidation in Public Health Wales. Board/Committee to-
More informationReview of Local Enhanced Services
Review of Local Enhanced Services 1. Background and context 1.1 CCGs are required to prepare for the phasing out of LESs by April 2014 by reviewing the existing LES portfolio and developing commissioning
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationLooked After Children Annual Report
Looked After Children Annual Report Reporting period April 2016 March 2017 Authors Maxine Lomax - Designated Nurse for Child Protection & Looked After Children Dr. Bin Hooi Low - Designated Doctor for
More information5. Does this paper provide evidence of assurance against the Governing Body Assurance Framework?
Item Number: 6.3 Governing Body Meeting: 4 February 2016 Report Sponsor Anthony Fitzgerald Director of Strategy and Delivery Report Author Anthony Fitzgerald Director of Strategy and Delivery 1. Title
More informationLocal Enhanced Service Agreement 1 July March 2016
Local Enhanced Service Agreement 1 July 2013 31 March 2016 Recognition and Management of People with Dementia and their Family/Carers in General Practices in Bristol Agreement between NHS Bristol Clinical
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,
More informationINDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board
INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation
More informationCoastal West Sussex Interface Prescribing Policy
Coastal West Sussex Interface Prescribing Policy Agreement between Commissioners: Coastal West Sussex CCG And Providers: Western Sussex NHS Foundation Trust (WSfT) Sussex Community NHS Trust (SCT) Sussex
More informationPersonal Budgets and Direct Payments
Personal Budgets/Direct Payments Date of resource : April 20 Page 1 of Learning Aims The learning aims of this briefing are to enable you to 1 Understand how personal budgets can be requested for special
More informationCCG Policy for Working with the Pharmaceutical Industry
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationPrinciples of Shared Care Protocols
Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the
More informationThe interface between primary and secondary care Key messages for NHS clinicians and managers
The interface between primary and secondary care Key messages for NHS clinicians and managers In partnership with: NHS England and NHS Improvement 2 Good organisation of care across the interface between
More informationPrime Ministers Challenge Fund
Prime Ministers Challenge Fund GP Recruitment - Information Pack GDoc Ltd Eastgate House, 121-131 Eastgate Street, Gloucester, GL1 1PX www.gdoc.org.uk Contents The Opportunity and Introduction 1 Background
More informationService Specification
Service Specification Minor Injuries Release: FINAL Date: 30/11/10 Author: Laura Smith Urgent Care Commissioning Manager NHS Derbyshire County Owner: Service Specification owner Owner s designation Owner
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationThe Integrated Support and Assurance Process (ISAP): guidance on assuring novel and complex contracts
The Integrated Support and Assurance Process (ISAP): guidance on assuring novel and complex contracts Part A: Introduction Published by NHS England and NHS Improvement August 2017 First published: Friday
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0
WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review
More informationDEPARTMENT OF EDUCATION DEVELOPMENT PROPOSALS FOR GRANT-AIDED SCHOOLS
DEPARTMENT OF EDUCATION DEVELOPMENT PROPOSALS FOR GRANT-AIDED SCHOOLS 2003 CONTENTS Page Introduction Consultation Format and content of Development Proposals Timing of Publication of Proposals Modification
More informationShared Care Agreements for Medicines
Shared Care Agreements for Medicines Author: Scott Garden, Chief Pharmacist, Acute Services Version: 1.0 Authorised by: NHS Fife Area Drug and Therapeutics Committee Date of Authorisation: Review Date:
More informationWOLVERHAMPTON CCG Commissioning Committee Wednesday 28 th September 2016
WOLVERHAMPTON CCG Wednesday Title of Report: Report of: Contact: Social Prescribing Proposal Andrea Smith Andrea Smith Action Required: Decision Assurance Purpose of Report: Public or Private: To present
More informationRegistration and Inspection Service
Registration and Inspection Service Children s Residential Centre Centre ID number: 020 Year: 2017 Lead inspector: Michael McGuigan Registration and Inspection Services Tusla - Child and Family Agency
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures
More informationPatient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationCommittee is requested to action as follows: Richard Walker. Dylan Williams
BetsiCadwaladrUniversityHealthBoard Committee Paper 17.11.14 Item IG14_60 NameofCommittee: Subject: Summary or IssuesofSignificance StrategicTheme/Priority / Valuesaddressedbythispaper Information Governance
More informationInvestment Committee: Extended Hours Business Case (Revised)
PAPER 06 Investment Committee: Extended Hours Business Case (Revised) OVERALL STRATEGY 1. SaHF Care Closer to Home This Extended Hours Business Case is developed within the context of Shaping a Healthier
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationShared-care arrangements and the primary/secondary-care interface
Shared-care arrangements and the primary/secondary-care interface Jas Khambh MRPharmS, DipPrescSci and Christian Barnick FRCOG Specialist and high-risk drugs are increasingly being prescribed in the community
More informationMENINGOCOCCAL SEROGROUP B IMMUNISATION FOR INFANTS. Service Specification
MENINGOCOCCAL SEROGROUP B IMMUNISATION FOR INFANTS Service Specification National Enhanced Service Specification for Meningococcal Serogroup B (MenB) Vaccination Programme. Introduction 1. This programme
More informationPatient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire
More informationManis Aged Care Limited
Manis Aged Care Limited Introduction This report records the results of a Surveillance Audit of a provider of aged residential care services against the Health and Disability Services Standards (NZS8134.1:2008;
More informationPrevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
More informationJob Description. 65,000 to 80,000 per annum based on qualifications, skills and experience
Job Description Service Job Title Hours Salary Reports to Purpose of Job Specialty Doctor 37.5 hours per week 65,000 to 80,000 per annum based on qualifications, skills and experience Consultant Psychiatrist
More informationJOB DESCRIPTION LEAD PRACTICE BASED PHARMACIST. Designated GP Practice in Federation area
JOB DESCRIPTION JOB TITLE: LOCATION: ACCOUNTABLE TO: RESPONSIBLE TO: PROFESSIONALLY RESPONSIBLE TO: LEAD PRACTICE BASED PHARMACIST Designated GP Practice in Federation area Federation Chair Practice Prescribing
More informationPROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS
PROCEDURE FOR MEDICINES RECONCILIATION BY NURSING STAFF FOR PATIENTS ADMITTED TO THE COMMUNITY HOSPITALS OUT OF HOURS Policy Details NHFT document reference MMPr030 Version 22/02/16 Date Ratified May 2016
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationStaffing Regulations for Aged Residential Care Facilities Consultation Document
Staffing Regulations for Aged Residential Care Facilities Consultation Document Published in November 2004 by the Ministry of Health PO Box 5013, Wellington, New Zealand ISBN 0-478-25764-3 (Internet) HP
More informationUnlicensed Medicines Policy Document
Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale
More informationNPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing
NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix
More informationSystmOne COMMUNITY OPERATIONAL GUIDELINES
SystmOne COMMUNITY OPERATIONAL GUIDELINES Guidelines IM&T 11 Date: August 2007 Document Management Title of document SystmOne Community Operational Guidelines Type of document Guidelines IM&T 11 Description
More informationQuality Assurance Framework Adults Services. Framework. Version: 1.2 Effective from: August 2016 Review date: June 2017
Quality Assurance Framework Adults Services Framework Version: 1.2 Effective from: August 2016 Review date: June 2017 Signed off by: Sharon Gogan Title: Head of Adult Social Care Date: 20 th May 2014 Quality
More informationNHS. The guideline development process: an overview for stakeholders, the public and the NHS. National Institute for Health and Clinical Excellence
NHS National Institute for Health and Clinical Excellence Issue date: April 2007 The guideline development process: an overview for stakeholders, the public and the NHS Third edition The guideline development
More informationQuality and Governance Committee. Terms of Reference
Quality and Governance Committee Terms of Reference 1. Constitution 1.1 The Clinical Commissioning Group s Governing Body hereby resolves to establish a Committee of the Governing Body known as the Quality
More informationPrimary Care Quality (PCQ) National Priorities for General Practice
Primary Care Quality (PCQ) National Priorities for General Practice Cluster Guidance and Templates 2015/16 Authors: Primary Care Quality Team Date: November 2015 Publication/ Distribution: Version: Final
More informationDelegated Commissioning of Primary Medical Services Briefing Paper
Appendix One Delegated Commissioning of Primary Medical Services Briefing Paper 1.0 Introduction Swindon CCG has been jointly commissioning Primary Medical Services with NHS England under co-commissioning
More informationSharing Healthcare Records
On behalf of: NHS Leeds North Clinical Commissioning Group NHS Leeds South and East Clinical Commissioning Group NHS Leeds West Clinical Commissioning Group Sharing Healthcare Records An overview of healthcare
More informationCOMMUNITY DEVELOPMENT AND SUPPORT EXPENDITURE SCHEME GUIDELINES
COMMUNITY DEVELOPMENT AND SUPPORT EXPENDITURE SCHEME GUIDELINES November 2009 Gaming Machine Tax Act 2001 First published October 2007 Revised July 2008 Revised February 2009 Revised November 2009 CONTENTS
More informationPGDs are permitted for use only by registered health professionals (see enclosed link for full list
NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred
More informationPatient Survey Analysis and Action Plan - 15 th January 2014
Patient Survey Analysis and Action Plan - 15 th January Key Areas Comments and Actions Action for Extended Hours 90% said current provision is convenient Those who didn t agree said extended hours appointments
More informationOverview of the TOUCH Program
Overview of the TOUCH Program Please see accompanying full Prescribing Information, including Boxed Warning. INDICATIONS AND USAGE Multiple Sclerosis (MS) TYSABRI (natalizumab) is indicated as monotherapy
More information